Get 14 day free trial
1. Lemmy and Iggy, two carrion crows, are no strangers to a psychology lab. As study participants, they have helped scientists prove that birds can use tools to forage, learn numbers and count objects, and provided other insights into the ways birds think. Now, they’ve also revealed that birds can make staggeringly quick decisions, besting their human and nonhuman primate counterparts with ease. In new findings published in Science, the crows could process and respond to visual cues at twice the speed as humans and monkeys, quantifying the neural speed of avian decision-making for the first time. The discovery might be the final blow for the use of “birdbrains” as a pejorative. “We wouldn’t think of birds making these decisions faster than monkeys, or faster than us ‘awesome’ human beings,” said Mike Colombo, a neuroscientist and comparative psychologist at the University of Otago in New Zealand who was not involved in the research. “But they do. They’re just incredibly fast.” (Sources: science.org, nytimes.com)
**2. Scientists in the **Center for Human Brain Variation at the Broad Institute have charted previously hidden architecture and patterns of cellular makeup in a key part of the brain called the striatum, which is involved in decision-making and movement and is affected in psychiatric disorders, addiction, and neurodegeneration. The findings reveal six new zones within the striatum based on gene expression patterns. They also demonstrate how the zones’ boundaries blur with age and highlight ways that advancing age and genetic variation affect gene expression in the brain. The discoveries are from Broad-led studies that appear alongside two dozen other studies in Cell and related journals from hundreds of scientists in the BRAIN Initiative Cell Atlas Network (BICAN), a flagship project of the National Institutes of Health’s BRAIN Initiative, which aims to build a detailed cellular map of the human brain. (Sources: brain.broadinstiutute.org, cell.com, brain-bican.org)
**3. Inoculations for shingles, the respiratory syncytial virus (RSV), pneumococcal disease, tetanus, and diphtheria have all been tied to a reduced risk of dementia. The annual flu vaccine is also part of the mix. But a new study suggests that a stronger dose **could be even better for dementia risk, compared to a standard flu shot. When researchers at the University of Texas Health Science Center at Houston analyzed the health data of nearly 165,000 adults aged 65 and older, they found that those who received a high-dose influenza vaccine had up to a 22 percent lower risk of developing Alzheimer’s disease over the following two years than those given a standard-dose shot. Combined with earlier findings for people with no flu vaccination, that’s nearly a 55 percent lower risk of developing Alzheimer’s disease, according to UTHealth Houston. (Sources: sciencealert.com, neurology.org)
**4. **Rana Foroohar:
The manufacturing sector in the US is having a renaissance, not just in terms of output but more recently jobs. Major investments into advanced manufacturing — think chips, pharmaceuticals, chemicals, computers and electronics — took year-on-year production growth in US factories from -1.7 per cent in 2024 to 2 per cent in 2025 to 4 per cent this year. That’s the strongest sustained growth since Covid. Hiring finally rebounded in 2026, with 58,000 new jobs created as of October. These jobs pay about a third more than old line factory work, as they require highly technically skilled workers who are as likely to programme robots or leverage AI as they are to drill or weld by hand. (Source: ft.com)
Read more